Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Quickcomparison

Dose Range Macimorelin 25–60 mg MK-677 (Ibutamoren) 10–25 mg Frequency As needed Once daily Administration Oral (reconstituted solution) Oral (capsule or liquid) Cycle Length 4-6 weeks 8-12 weeks Onset Speed Rapid (hours to days) Moderate (1-2 weeks) Evidence

This comparison does not assign a generated winner or score.

  • Dose Range
  • Macimorelin
  • 25–60 mg
  • MK-677 (Ibutamoren)
  • 10–25 mg
  • Frequency
  • As needed
  • Once daily
  • Administration
  • Oral (reconstituted solution)
  • Oral (capsule or liquid)
  • Cycle Length
  • 4-6 weeks
  • 8-12 weeks
  • Onset Speed
  • Rapid (hours to days)
  • Moderate (1-2 weeks)
  • Evidence Level
  • Strong human trials (Phase 3 or FDA approved)
  • Moderate human trials (Phase 1-2)
  • Efficacy
More references

Related material

Comparison

Quickcomparison

Dose Range SM-130686 5–20 mg MK-677 (Ibutamoren) 10–25 mg Frequency Multiple times daily Once daily Administration Oral capsule or powder Oral (capsule or liquid) Cycle Length 8-1…

View details →
Comparison

Quickcomparison

Dose Range Capromorelin 3–30 mg MK-677 (Ibutamoren) 10–25 mg Frequency Once daily Administration Oral (capsule or tablet) Oral (capsule or liquid) Cycle Length 4-6 weeks 8-12 week…

View details →